METOPROLOL IV VIATRIS is used to treat an irregular heartbeat, also known as arrhythmia, which means that there is a disturbance of the heart's normal rhythm or beat.

For patients with ST-segment-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention within six hours of symptom onset, the early administration of ...

Patients randomized to metoprolol received at least 1 5-mg IV bolus (82% and 67% received 2 and 3 5-mg boluses, respectively). All patients, except for those who developed contraindications, received ...

Current guidelines advocate only for initiation of beta blockade in patients presenting with an infarct. The METOCARD-CNIC trial examined IV metoprolol prior to reperfusion. Will it change practice?

Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: Randomised placebo-controlled trial. Lancet 2005 Nov 5; 366:1622-32.

Metoprolol, a beta-1 adrenergic receptor antagonist, ... Patients with acute myocardial infarction (AMI) were randomized to receive intravenous (IV) metoprolol 15mg or control pre-reperfusion.

Intravenous metoprolol (a β 1-selective blocker) before percutaneous coronary intervention (PCI) in selected patients with ST-segment elevation myocardial infarction (STEMI) reduces infarct size ...

In the METOCARD-CNIC trial, the patients who derived cardioprotection were the ones given metoprolol further ahead of intervention. EARLY-BAMI, planned before the results of that trial were known, had ...

The researchers therefore propose intravenous metoprolol as a “promising intervention that could improve the prognosis of severely ill COVID-19 patients.” ...